TYSON TIMOTHY received a stock award from SYROS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/2/2023ACC: 0001209191-23-033732
+10K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4K
Price / share
—
Trade value
—
% of position
15.9%
6/1/2023
25.19K→29.19K
Total
Net shares
+4K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2023 | A · Award | +4K | — | — | 15.9% | 25.19K | 29.19K |
| Total | +4K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
6K shares
Shares
+6K
Strike price
3.70
Held after
6K
Exercisable
—
6/1/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock6K shares | 6/1/2023 | A · Award | +6K | 3.70 | — | 6K |